Assistant Professor, Radiation Oncology, Oakland University Wm Beaumont SOM
Hematology
Dr. Efstathios S. Tapazoglou, MD
|
|
Give Review
Dr. Efstathios S. Tapazoglou is an expert in the field of Hematology. He graduated from Wayne State University School of Medicine. Wayne State University School of Medicine is ranked 63 in research and 85 in primary care medicine He has 1 awards "Top MD". Efstathios S. Tapazoglou, MD is also a published doctor. He has 27 publication published. The most recent publication is: A double-blind, randomized study of two different dosage regimens of intravenous dolasetron in patients receiving high-dose cisplatin chemotherapy. He is registered with Medicare and accepts Medicare payments.
Publications
- Trisomy 15, sex chromosome loss, and hematological malignancy.
- A double-blind, randomized study of two different dosage regimens of intravenous dolasetron in patients receiving high-dose cisplatin chemotherapy.
- Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of Acute cisplatin-indu...
- Role of sialyltransferase in hypercupraemia of non-Hodgkin''s lymphoma.
- Disseminated intravascular coagulation and plasma cell Leukemia.
- Decreased natural killer Cell activity in patients with zinc deficiency with sickle Cell disease.
- The activity of a single-agent 5-fluorouracil infusion in advanced and recurrent head and neck Cancer.
- Meningeal carcinomatosis in head and neck Cancer. Report of six cases and review of the literature.
- Activity of flavone acetic acid (NSC-347512) against solid tumors of mice.
- Response rate and toxicity with aziridinylbenzoquinone in patients with recurrent Gliomas. A progress report.
- Intracranial Astrocytoma with diffuse bone marrow metastasis: a case report and review of the literature.
- An intensive, five course, alternating combination chemotherapy induction regimen used in patients with advanced, unresectable head and neck Cancer.
- Chemotherapy of the squamous cell lung Cancer LC-12 with 5-fluorouracil, cisplatin, carboplatin or iproplatin combinations.
- Phase II evaluation of aclacinomycin-A in patients with adenocarcinoma and large Cell carcinoma of the lung.
- High-dose ketoconazole therapy in patients with metastatic prostate Cancer.
- Metastatic squamous Cell carcinoma of an unknown primary localized to the neck. Advantages of an aggressive treatment.
- Cellular DNA content parameters in untreated and recurrent squamous cell Cancers of the head and neck.
- GR 38032F (GR-C507/75): a novel compound effective in the prevention of Acute cisplatin-induced emesis.
- Chemotherapy for paranasal sinus Carcinoma. A 10-year experience at Wayne State University.
- Nonoperative therapy for squamous-cell Cancer of the esophagus.
- Achievement of superior survival for histologically negative versus histologically positive clinically complete responders to cisplatin combination in patients with lo...
- Discrepancy between cytotoxicity and DNA interstrand crosslinking of carboplatin and cisplatin in vivo.
- Ondansetron for the prevention of emesis induced by high-dose cisplatin. A multi-center dose-response study.
- The role of infection in the morbidity and mortality of patients with head and neck Cancer undergoing multimodality therapy.
- The incidence and significance of thromboembolic complications in patients with high-grade Gliomas.
- Whole body hyperthermia and carboplatin: cytotoxicity for murine leukaemia and normal marrow.
Schools
Faculty of Medicine of Aristotle University of Thessaloniki
Oakwood Hospital
Wayne St University Affil Hosps
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Awards
- Top MD
Education
-
Wayne State University School of Medicine -
Aristotle University of Thessaloniki School of Medicine
Hospital
-
St. John Hospital and Medical Center -
Henry Ford Hospital
Drug Facts
| NPI NUMBER | 1821070798 | |
| NPPES Provider LastName | TAPAZOGLOU | |
| NPPES Provider FirstName | EFSTATHIOS | |
| NPPES Provider ZIPCode | 480933400 | |
| NPPES Provider State | MI | |
| Specialty Description | Critical Care (Intensivists) | |
| Total Claim Count | 4036.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 377.0 | |
| Percent Opioid Claims | 9.34 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1821070798 |
| Last Name Of The Provider | TAPAZOGLOU |
| First Name Of The Provider | EFSTATHIOS |
| View All |
Similar Doctors
|
Dr. Lynette Sutkowi-Toomajian, DO
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Dawn M. Severson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert Waldmann, DO |
|
|
Dr. Michael G. Bayerl, MD |